Association of serum magnesium level with resistant hyperlipidemia in diabetic and hypertensive patients

Introduction: Both diabetes mellitus and hypertension are aspects of metabolic syndrome. Objectives: The aim of this study was to determine the relationship between serum magnesium level with resistant hyperlipidemia in a group of diabetic and hypertensive patients. Patients and Methods: The...

Full description

Bibliographic Details
Main Authors: Pardis Kaveh, Afsaneh Malekpour Tehrani, Saeid Mardani
Format: Article
Language:English
Published: Society of Diabetic Nephropathy Prevention 2020-01-01
Series:Journal of Nephropharmacology
Subjects:
Online Access:http://jnephropharmacology.com/PDF/npj-2296
Description
Summary:Introduction: Both diabetes mellitus and hypertension are aspects of metabolic syndrome. Objectives: The aim of this study was to determine the relationship between serum magnesium level with resistant hyperlipidemia in a group of diabetic and hypertensive patients. Patients and Methods: The present cross-sectional study was carried out on 90 hypertensive and diabetic patients who referred to outpatient university clinic in Shahrekord (45 hypertensive and 45 diabetic patients). Included patients had high triglyceride levels despite 8 weeks of treatment with lipid-lowering agents. Results: There was an inverse significant relationship between serum magnesium and triglyceride levels in diabetic patients (P=0.002, r=-0.458), however, this correlation was not significant in hypertensive patients (P=0.754, r=0.048). Conclusion: This study showed, serum magnesium may affect triglycerides levels in diabetic patients, however, our finding requires further investigation with larger population.
ISSN:2345-4202